-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on Tenet Healthcare, Raises Price Target to $240

Benzinga·11/21/2025 17:43:24
Listen to the news
Barclays analyst Andrew Mok maintains Tenet Healthcare (NYSE:THC) with a Overweight and raises the price target from $229 to $240.